Bibliography
- Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2008. Washington, DC: Pharmaceutical Research and Manufacturers of America, March 2008. Available from: http://www.phrma.org/files/2008%20Profile.pdf [Last accessed 15 September 2008]
- Di Masi JA, Grabowski HG. The Cost of Biopharmaceutical R&D: Is biotech different? Manag Decis Econ 2007;28:469-79. Available from: http://fds.duke.edu/db?attachment-25-1301-view-325 [Last accessed 15 September 2008]
- Congressional Budget Office. Research and Development in the Pharmaceutical Industry. Washington, DC: Congressional Budget Office, October 2006. Available from: http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf [Last accessed 15 September 2008]
- Pfizer. Pfizer, Inc. 2007 Financial Report. New York, NY: Pfizer, 2008. Available from: http://media.pfizer.com/files/annualreport/2007/financial/financial2007.pdf [Last accessed 16 September 2008]
- Microsoft Corporation. Microsoft Corporation Annual Report 2007. Redmond, WA; Microsoft Corporation, 2008. Available from: http://www.microsoft.com/msft/reports/ar07/staticversion/index.html [Last accessed 16 September 2008]
- Ford Motor Company. Ford Motor Company Annual Report 2007. Dearborn, MI; Ford Motor Company, 2008. Available from: http://www.ford.com/doc/2007_ar.pdf [Last accessed 16 September 2008]
- Berenson A. End of Drug Trial is a big loss for Pfizer. The New York Times 2006 December 4. Available from: http://www.nytimes.com/2006/12/04/health/04pfizer.html?pagewanted=1&sq=Torcetrapib&st=cse&scp=7 [Last accessed 28 September 2008]
- IMS Health. Intelligence.360 – Global Pharmaceutical Perspectives 2007. Norwalk, CT: IMS Health, 2008. Available from: http://www.imshealth.com/portal/site/imshealth/menuitem.c96f97d74b76899c33a004f09418c22a/?vgnextoid=b04e51dd68585110VgnVCM10000071812ca2RCRD&vgnextfmt=default [Last accessed 17 September 2008]
- Houlton S. Drug industry slims down to shape up. Chemistry World 2008 January. Available from: http://www.rsc.org/chemistryworld/Issues/2008/January/DrugIndustrySlimsDownToShapeUP.asp [Last accessed 20 September 2008]
- Malik N. Has the era of blockbuster drugs come to an end? BioPharm International 2007 December 1. Available from: http://biopharminternational.findpharma.com/biopharm/Final+Word/Has-the-Era-of-Blockbuster-Drugs-Come-to-an-End/ArticleStandard/Article/detail/477611 [Last accessed 28 September 2008]
- Pollack A. AstraZeneca Acquires a Biotech Company. The New York Times 2007 April 24. Available from: http://www.nytimes.com/2007/04/24/business/24drug.html?scp=1&sq=astrazeneca+medimmune&st=nyt [Last accessed 28 September 2008]
- Pollack A. Roche offers $43.7 billion for shares in Genentech It does not already own. The New York Times 2008 July 22. Available from: http://www.nytimes.com/2008/07/22/business/worldbusiness/22roche.html?scp=2&sq=genentech%20roche&st=nyt [Last accessed 28 September 2008]
- Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006;355:1018-28. Available from: http://content.nejm.org/cgi/content/full/355/10/1018 [Last accessed 19 September 2008]
- Department of Health. Expert Group on Phase One Clinical Trials: Final Report. London, UK; Department of Health, December 2006. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_063117 [Last accessed 20 September 2008]
- European Medicines Agency. Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products. London, UK; European Medicines Agency, July 2007. Available from: http://www.emea.europa.eu/pdfs/human/swp/2836707enfin.pdf [Last accessed 20 September 2008]
- World Medical Association. Declaration of Helsinki. World Medical Association 1964. Available from: http://www.wma.net/e/policy/pdf/17c.pdf [Last accessed 18 September 2008]
- Whalen J. Overseas Drugs Hit U.S. Regulatory Snags. Wall Street Journal 2008 March 26. Available from: http://online.wsj.com/article/SB120648160360663519.html?mod=dist_smartbrief [Last accessed 22 September 2008]
- Merck. TREDAPTIVE™ (nicotinic acid/laropiprant) approved in the European Union: new lipid-modifying therapy to treat LDL-C, HDL-C and triglycerides [press release]. Merck 2008 July 11. Available from: http://www.merck.com/newsroom/press_releases/corporate/2008_0711.html [Last accessed 22 September 2008]
- Merck. Merck provides update on US regulatory status of MK-0524A (ER niacin/laropiprant) and MK-0524B (ER niacin/laropiprant/simvastatin) [press release]. Merck 2008 June 20. Available from: http://www.merck.com/newsroom/press_releases/research_and_development/2008_0620.html [Last accessed 22 September 2008]
- Schmit J. FDA caution, ‘research drought’ cuts drug approvals. USA Today 2008 February 4. Available from: http://www.usatoday.com/money/industries/health/2008-02-03-fda-drugs_N.htm?loc=interstitialskip [Last accessed 28 September 2008]
- Feuerstein A. Elan-Wyeth Alzheimer's Data Spook Bulls. TheStreet.com 2008 July 30. Available from: http://www.thestreet.com/story/10430988/1/elan-wyeth-alzheimers-data-spook-bulls.html [Last accessed 28 September 2008]